Clover Health CLOV 深 沪
等待开盘 04-01 09:30:00 美东时间
1.76
+0.040
+2.33%
华盛通- 最 高1.79
- 今 开1.729
- 成交量 683.66万股
- 最 低 1.695
- 昨 收 1.72
- 总市值 9.24亿
- 52周最高 3.92
- 市盈率 静 --
- 换手率 1.30%
- 52周最低 1.695
- 委 比 -57.51%
- 总股本 5.25亿
- 历史最高 28.85
- 量 比 1.52
- 振 幅 5.52%
- 历史最低 0.606
- 每 手 1
- 风险率 0.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Clover Health's Subsidiary Publishes Whitepaper on "Driving Clinical Excellence in Chronic Disease" Highlighting Use of Counterpart Assistant Associated With 18%–22% Fewer Flu-Related Acute Care Events Among COPD And CHF Patients
Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), and a leading AI-powered physician-enablement platform
03-19 20:36
Clover Health study links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients
Clover Health study links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients Counterpart Health, a Clover subsidiary, released a whitepaper analyzing how use of Counterpart Assistant flu-related clinical insights affected vaccination rates and flu-related acute
03-19 20:35
Clover unit Counterpart Health links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients
Clover unit Counterpart Health links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients Counterpart Health, a wholly owned subsidiary of Clover Health, released a whitepaper on Counterpart Assistant and flu preventive care in Clover’s Medicare Advantage populat
03-19 20:32
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
Counterpart Health's new whitepaper reveals that patients whose primary care physicians (PCPs) used the Counterpart Assistant’s flu-related insights were 1.89 times more likely to receive a flu vaccination. Additionally, patients with chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) saw significantly fewer flu-related hospitalizations and emergency visits. The analysis, conducted within Clover Health’s Medicare Adva...
03-19 12:30
Rising employee health insurance costs dampened wage growth: Fed survey
The Federal Reserve Bank of New York estimated on Wednesday that rising employee health insurance costs, driven by increased healthcare spending due to GLP-1 obesity drugs and other factors, dragged w...
03-05 00:58
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
Clover Health, Kno2, and Counterpart Health have partnered to enable real-time patient access to clinical and claims data using standardized FHIR formats, making Clover the first payer live on a CMS Aligned Network and TEFCA. This collaboration advances CMS’s vision for interoperable data exchange, supporting coordinated care for Medicare patients with chronic conditions. Powered by Counterpart Health’s infrastructure, Clover Health can securely ...
03-04 13:30
电话会总结 ｜ Clover Health(CLOV)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Clover Health业绩会实录，以下是2025年财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 2025年全年总收入同比增长40% - 保险收入达到19亿美元，同比增长41% - 第四季度保险收入4.86亿美元，同比增长47% **盈利能力：** - 首次实现全年调整后EBITDA盈利，达到2200万美元 - 调整后净收入2000万美元 - 新引入的合并毛利润指标达到3.56亿美元 - 保险业务费用比率(BER)为90.9%，同比上升970个基点 **现金流状况：** - 年末现金及投资总额3.2亿美元，其中非监管子公司持
02-27 12:24
财报速睇 | CLOVER HEALTH INVESTMENTS CORP 2025财年Q4营收4.88亿美元，同比增长44.7%；归母净利润亏损0.49亿美元，同比亏损扩大123.3%
华盛资讯2月27日讯，CLOVER HEALTH INVESTMENTS CORP公布2025财年Q4业绩，公司Q4营收4.88亿美元，同比增长44.7%，归母净利润亏损0.49亿美元，同比亏损扩大123.3%。
02-27 06:16
Clover Health sees 2026 revenue above consensus
Clover Health Investments (CLOV) is projecting 2026 revenue of $2.81B-$2.92B, above the consensus estimate of $2.74B. This year, the company also sees Medicare Advantage membership of 154,000-158,000....
02-27 05:49
